Orbit Discovery
Pre-clinicalOrbit Discovery finds peptide conjugates for precise radionuclide delivery. Using bead-based technology and flow cytometry, we identify high-affinity peptides for tumor-specific targets. Our diverse peptide libraries enhance target specificity while minimising off-target effects.
Founded
2015
Focus
Drug DeliveryAI / Machine LearningAntibodies
About
Orbit Discovery finds peptide conjugates for precise radionuclide delivery. Using bead-based technology and flow cytometry, we identify high-affinity peptides for tumor-specific targets. Our diverse peptide libraries enhance target specificity while minimising off-target effects.
Funding History
2Total raised: $30.5M
Series A$28MBoehringer Ingelheim Venture FundJun 15, 2021
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationOxford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile